SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-12
👔
Apogee Therapeutics, Inc.
@APGE_InsiderForm 4 Filing: Shah Nimish P Acquires (Grant) shares of $APGE
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Apogee Therapeutics, Inc.
Ticker: $APGE
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-09
Shares: 7,657
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Shah Nimish P, holds the title of Director at Apogee Therapeutics, Inc..
On 2026-06-09, the insider transacted 7,657 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Shah Nimish P (Director) was granted $0 of $APGE
Post-Transaction Position: 7,657 shares
SEC Accession No: 0001104659-26-073061 (CIK: 1698082)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.